DYN
Dyne Therapeutics Inc
15.40$
+1.6%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +31.6% | -31.9% | +3.6% | +9.5% | +2.7% | +11.6% | +0.2% | -0.6% | +4.2% | +5.6% | +1.8% | – | |
| – | +17.5% | +247.4% | -66.2% | +29.8% | +19.8% | +24.3% | -19.2% | +5.3% | +1.3% | +16.5% | +14.5% | – | |
| – | +467.3% | -228.6% | – | +234.2% | -135.9% | – | – | +4.0% | -292.8% | – | – | – | |
| – | -50.9% | +132.9% | +348.7% | -70.5% | +324.9% | -8.7% | -93.9% | +31,875.0% | -97.5% | -54.3% | +585.1% | – | |
| – | +104.3% | -786.5% | – | -273.6% | -17.5% | – | +364.6% | -660.5% | – | -343.6% | +100.5% | – | |
| – | – | – | – | – | – | – | – | -100.0% | – | -87.4% | +824.3% | – | |
| – | -67.6% | +277,715.0% | -7.0% | -95.3% | -79.8% | +3,784.5% | -28.7% | +115.7% | +98.3% | -98.4% | +722.6% | – | |
| – | – | – | +124.1% | -122.6% | – | – | -65.1% | +589.5% | +261.4% | -143.8% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.